Compile Data Set for Download or QSAR
Report error Found 160 Enz. Inhib. hit(s) with all data for entry = 11841
TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652266(US11905306, No. 53)
Affinity DataEC50:  62nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652288(US11905306, No. 75)
Affinity DataEC50:  65nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652257(US11905306, No. 44)
Affinity DataEC50:  70nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652288(US11905306, No. 75)
Affinity DataEC50:  128nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652263(US11905306, No. 50)
Affinity DataEC50:  130nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652220(US11905306, No. 7)
Affinity DataEC50:  160nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652257(US11905306, No. 44)
Affinity DataEC50:  160nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652278(US11905306, No. 65)
Affinity DataEC50:  160nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652289(US11905306, No. 76)
Affinity DataEC50:  172nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652266(US11905306, No. 53)
Affinity DataEC50:  180nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652263(US11905306, No. 50)
Affinity DataEC50:  180nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652286(US11905306, No. 73)
Affinity DataEC50:  180nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652289(US11905306, No. 76)
Affinity DataEC50:  189nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652261(US11905306, No. 48)
Affinity DataEC50:  210nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652222(US11905306, No. 9)
Affinity DataEC50:  210nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652285(US11905306, No. 72)
Affinity DataEC50:  240nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652282(US11905306, No. 69)
Affinity DataEC50:  240nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652220(US11905306, No. 7)
Affinity DataEC50:  260nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652256(US11905306, No. 43)
Affinity DataEC50:  260nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652222(US11905306, No. 9)
Affinity DataEC50:  260nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652271(US11905306, No. 58)
Affinity DataEC50:  300nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652234(US11905306, No. 21)
Affinity DataEC50:  320nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652249(US11905306, No. 36)
Affinity DataEC50:  350nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652239(US11905306, No. 26)
Affinity DataEC50:  350nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652276(US11905306, No. 63)
Affinity DataEC50:  430nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652248(US11905306, No. 35)
Affinity DataEC50:  430nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652282(US11905306, No. 69)
Affinity DataEC50:  450nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652261(US11905306, No. 48)
Affinity DataEC50:  450nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652286(US11905306, No. 73)
Affinity DataEC50:  450nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652278(US11905306, No. 65)
Affinity DataEC50:  460nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652221(US11905306, No. 8)
Affinity DataEC50:  470nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652275(US11905306, No. 62)
Affinity DataEC50:  480nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652249(US11905306, No. 36)
Affinity DataEC50:  490nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652239(US11905306, No. 26)
Affinity DataEC50:  490nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652279(US11905306, No. 66)
Affinity DataEC50:  490nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652271(US11905306, No. 58)
Affinity DataEC50:  500nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652264(US11905306, No. 51)
Affinity DataEC50:  510nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652285(US11905306, No. 72)
Affinity DataEC50:  510nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652234(US11905306, No. 21)
Affinity DataEC50:  520nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652281(US11905306, No. 68)
Affinity DataEC50:  520nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652264(US11905306, No. 51)
Affinity DataEC50:  520nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652256(US11905306, No. 43)
Affinity DataEC50:  520nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652238(US11905306, No. 25)
Affinity DataEC50:  520nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652252(US11905306, No. 39)
Affinity DataEC50:  530nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652253(US11905306, No. 40)
Affinity DataEC50:  530nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652276(US11905306, No. 63)
Affinity DataEC50:  550nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652230(US11905306, No. 17)
Affinity DataEC50:  610nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652274(US11905306, No. 61)
Affinity DataEC50:  710nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652229(US11905306, No. 16)
Affinity DataEC50:  750nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652251(US11905306, No. 38)
Affinity DataEC50:  750nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

Displayed 1 to 50 (of 160 total ) | Next | Last >>
Jump to: